Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
10000 participants
OBSERVATIONAL
2025-09-01
2027-03-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Patients will be eligible for participation if: 1) adult and 2) receiving intraoperative ventilation during general anesthesia for surgery. Patients receiving ventilation outside of an operating room as well as patients receiving intraoperative ventilation during extracorporeal life support will be excluded
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Outcome and Predictors of Mortality of Patients on Prolonged Mechanical Ventilation
NCT06087939
PROtective Ventilation With FLOW-Controlled Ventilation
NCT06703814
Two Modes of Mechanical Ventilation for Intensive Care Patients With Low Blood Oxygen Due to Breathing Difficulties
NCT06140056
Diaphragm Protective Ventilation in the Intensive Care Unit
NCT03527797
Determination of the Optimal Spontaneous Breathing Trial During Weaning of Mechanical Ventilation
NCT04222569
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Patients will be eligible for participation if: 1) adult and 2) receiving intraoperative ventilation during general anesthesia for surgery. Patients receiving ventilation outside of an operating room as well as patients receiving intraoperative ventilation during extracorporeal life support will be excluded.
The primary endpoint is to report the number of patients with PPCs occurring in the first 5 postoperative days. As secondary endpoint, the practice of mechanical ventilation in patients undergoing general anesthesia for surgery will be ascertained including key intraoperative ventilator characteristics and respiratory system mechanics. Other secondary endpoints will include: incidence and type of IAEs; postoperative complications other than PPCs in the first 5 postoperative days; intensive care unit (ICU) admission and length of stay, hospital length of stay, and hospital mortality on day 28.
Participating hospitals have the flexibility to choose a specific time period for data collection, but it is imperative that this process occurs within 8 weeks from receiving approval by the local Ethics Committee. Furthermore, each participating center will conduct data collection during a predetermined 7-day period. Local investigators will capture data in an electronic case recording form, including patient demographics and baseline characteristics, intraoperative ventilator settings and ventilation parameters, and outcomes.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intraoperative mechanical ventilation
Patients subjected to invasive mechanical ventilation (IMV) during general anesthesia for surgery
Intraoperative mechanical ventilation for surgery
Any IMV during general anesthesia for surgery
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Intraoperative mechanical ventilation for surgery
Any IMV during general anesthesia for surgery
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Receiving intraoperative IMV (via tracheal intubation, or supraglottic device ) during general anesthesia for surgery
Exclusion Criteria
* Receiving intraoperative IMV during extracorporeal life support
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Of Perugia
OTHER
University of Chieti
OTHER
Medical University of Vienna
OTHER
The Netherlands Cancer Institute
OTHER
Monash University
OTHER
Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Gianmaria Cammarota
Prof Gianmaria Cammarota
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gianmaria Cammarota, Prof
Role: PRINCIPAL_INVESTIGATOR
Università degli Studi del Piemonte Orientale
Rachele Simonte, MD
Role: STUDY_DIRECTOR
University Of Perugia
Edoardo M De Robertis, Prof
Role: STUDY_DIRECTOR
University Of Perugia
Sabrine N.T. Hemmes, MD
Role: STUDY_DIRECTOR
Department of Anesthesiology The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
Marcus J Schultz, Prof
Role: STUDY_DIRECTOR
Department of Anaesthesia, General Intensive Care & Pain Management, Medical University of Vienna
Salvatore M Maggiore, Prof
Role: STUDY_CHAIR
Department of Anesthesiology and Intensive Care, Ospedale SS Annunziata & Department of Innovative Technologies in Medicine and Odonto-stomatology, Università Gabriele D'Annunzio di Chieti-Pescara, Chieti, Italy
Ary Serpa Neto, Prof
Role: STUDY_DIRECTOR
Australian and New Zealand Intensive Care Research Centre (ANZIC-RC), School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UPO#1!
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.